{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T20:54:42Z","timestamp":1762808082765},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/wno.0b013e31821a91fe","type":"journal-article","created":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T09:07:22Z","timestamp":1305277642000},"page":"214-216","source":"Crossref","is-referenced-by-count":16,"title":["Early Diagnosis of Horner Syndrome Using Topical Apraclonidine"],"prefix":"10.1097","volume":"31","author":[{"given":"Johnathan","family":"Cooper-Knock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basil","family":"Sharrack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210126","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00055735-200312000-00007","article-title":"Horner syndrome.","volume":"14","author":"Walton","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-5-20210126","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11910-007-0062-y","article-title":"Horners syndrome, pseudo-Horners syndrome, and simple anisocoria.","volume":"7","author":"Martin","year":"2007","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R3-5-20210126","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0024-3205(90)90132-B","article-title":"Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study.","volume":"46","author":"Ritz","year":"1990","journal-title":"Life Sci"},{"key":"R4-5-20210126","first-page":"83","article-title":"Topical apraclonidine in the diagnosis of suspected Horner syndrome.","volume":"25","author":"Freedman","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"R5-5-20210126","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/archopht.1987.01060090063028","article-title":"The safety and efficacy of topical 1% ALO (p-aminoclonidine hydrochloride) in normal volunteers.","volume":"105","author":"Abrams","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"R6-5-20210126","first-page":"506","article-title":"Apraclonidine in the diagnosis of Horners syndrome.","volume":"97","author":"Moodley","year":"2007","journal-title":"S Afr Med J"},{"key":"R7-5-20210126","first-page":"69","article-title":"Are we ready to replace cocaine with apraclonidine in the pharmacologic diagnosis of Horner syndrome?","volume":"25","author":"Kardon","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"R8-5-20210126","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7196\/SAMJ.3773","article-title":"Pharmacological testing in Horners syndromea new paradigm.","volume":"100","author":"Smit","year":"2010","journal-title":"S Afr Med J"},{"key":"R9-5-20210126","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jaapos.2007.02.015","article-title":"Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.","volume":"11","author":"Watts","year":"2007","journal-title":"J AAPOS"},{"key":"R11-5-20210126","first-page":"951","article-title":"Ocular effects of apraclonidine in Horner syndrome.","volume":"118","author":"Morales","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R12-5-20210126","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archopht.122.2.276","article-title":"The use of apraclonidine in the diagnosis of Horner syndrome in pediatric patients.","volume":"122","author":"Bacal","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R13-5-20210126","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archopht.121.8.1201","article-title":"The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome.","volume":"121","author":"Brown","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R14-5-20210126","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bjo.2005.074492","article-title":"The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.","volume":"89","author":"Koc","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R15-5-20210126","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ajo.2006.04.052","article-title":"Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.","volume":"142","author":"Chen","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R16-5-20210126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/WNO.0b013e318175d206","article-title":"Positive apraclonidine test within two weeks of onset of Horner syndrome caused by carotid artery dissection.","volume":"28","author":"Bohnsack","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"R17-5-20210126","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.iop.0000196322.05586.6a","article-title":"Effect of 0.5% apraclonidine on ptosis in Horner syndrome.","volume":"22","author":"Garibaldi","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R18-5-20210126","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/WNO.0b013e3181b1b41f","article-title":"Positive apraclonidine test 36 hours after acute onset of Horner syndrome in dorsolateral pontomedullary stroke.","volume":"30","author":"Lebas","year":"2010","journal-title":"J Neuroophthalmol"},{"key":"R19-5-20210126","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3129\/i08-162","article-title":"False-negative apraclonidine testing in acute Horner syndrome.","volume":"44","author":"Dewan","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"R20-5-20210126","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/bjo.2008.143487","article-title":"Denervation supersensitivity to 1% phenylephrine in Horner syndrome can be demonstrated 10 days after the onset of symptoms.","volume":"93","author":"Falzon","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R21-5-20210126","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-2008-1027349","article-title":"False negative apraclonidine test in two patients with Horner syndrome.","volume":"225","author":"Kawasaki","year":"2008","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"R22-5-20210126","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archophthalmol.2010.119","article-title":"Atypical acquired pediatric Horner syndrome.","volume":"128","author":"Pollard","year":"2010","journal-title":"Arch Ophthalmol"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNO.0b013e31821a91fe","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:42:33Z","timestamp":1620978153000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041327-201109000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e31821a91fe","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}